Toleikis; Lars
Patent Applications and Registrations
Patent applications and USPTO patent grants for Toleikis; Lars.The latest application filed is for "bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof".
- Toleikis; Lars - Kleinniedesheim DE
- Toleikis; Lars - Bundlesland DE
| Patent | Date |
|---|---|
| Bi-specific Antibodies For Enhanced Tumor Selectivity And Inhibition And Uses Thereof App 20220111064 - DOERNER; Achim ; et al. | 2022-04-14 |
| Aggrecan Binding Immunoglobulins App 20220089703 - Steffensen; Soren ; et al. | 2022-03-24 |
| Bi-specific antibodies for enhanced tumor selectivity and inhibition and uses thereof Grant 11,235,063 - Doerner , et al. February 1, 2 | 2022-02-01 |
| Aggrecan Binding Immunoglobulins App 20210115117 - Steffensen; Soren ; et al. | 2021-04-22 |
| Polypeptides Binding Adamts5, Mmp13 And Aggrecan App 20210008160 - STEFFENSEN; Soren ; et al. | 2021-01-14 |
| Mmp13 Binding Immunoglobulins App 20200190216 - DESCAMPS; Francis ; et al. | 2020-06-18 |
| Aggrecan Binding Immunoglobulins App 20200140532 - Steffensen; Soren ; et al. | 2020-05-07 |
| Monoclonal Antibody Directed To Fgfr1 App 20190367620 - IFFLAND; CHRISTEL ; et al. | 2019-12-05 |
| Anti-c-met Antibodies And Antibody Drug Conjugates Thereof For Efficient Tumor Inhibition App 20190248907 - DOERNER; Achim ; et al. | 2019-08-15 |
| Bi-specific Antibodies For Enhanced Tumor Selectivity And Inhibition And Uses Thereof App 20180326085 - DOERNER; Achim ; et al. | 2018-11-15 |
| Recombinant anti-MUC1 antibodies Grant 9,546,217 - Behrens , et al. January 17, 2 | 2017-01-17 |
| Bispecific aptamers mediating tumour cell lysis Grant 8,969,318 - Toleikis , et al. March 3, 2 | 2015-03-03 |
| Bispecific Aptamers Mediating Tumour Cell Lysis App 20140039042 - Toleikis; Lars ; et al. | 2014-02-06 |
| Recombinant Anti-muc1 Antibodies App 20110318757 - Behrens; Christian ; et al. | 2011-12-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 